We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Program Aims to Revolutionize Kidney Transplants

By HospiMedica staff writers
Posted on 21 Aug 2007
A new and innovative program to obtain donor organs, called living donor swap, has the potential to revolutionize kidney transplantation. More...


The new program, developed at the University of California, Los Angeles (UCLA, USA) enables the relative or friend of a kidney-transplant patient who is not compatible as a donor to swap organs with another potential donor who also may be an incompatible match for his or her relative or friend. This greatly broadens the pool of organs available from living donors. Currently, about two-thirds of kidney transplants are performed with organs taken from deceased donors, and the wait can often be as long as five years, making living-donor transplantation an attractive alternative. Living donors, often family or friends of the transplant patient, currently account for about one third of cases.

"Swapping organs makes sense in such cases,” said Albin Gritsch, M.D., a UCLA urologist. "In the case of a living donor swap, both transplants are done simultaneously; advances in living-donor-transplant technology make the surgery less invasive and the pain easier to manage.”

A similar approach was developed by investigators at the Johns Hopkins University School of Medicine (Baltimore, MD, USA) where living, non-directed (LND) kidney donations matched in a "domino paired donation” model resulted in a 60% increase in organ matching.


Related Links:
University of California Los Angeles
Johns Hopkins University School of Medicine

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.